Using the SEQC (n = 498) [27] and Kocak (n = 649) [28] NB cohorts, we analyzed the outcome of expression of GR, ERα, and RARα, either individually or in combination, for NB patient survival (Fig. 7). The gene discussed is NR3C1; the disease is neuroblastoma.